Podcast Episode Details

Back to Podcast Episodes

E126: Risk Signals, JAKs, and SELECTIVE-ity


Episode 127


Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do JAKs cause all the badness?" questions, but ultimately landing me about where I have been since ORAL-SURVEILLANCE was published

Paper: https://www.sciencedirect.com/science/article/pii/S0003496724423091

 


Published on 1 day, 10 hours ago






If you like Podbriefly.com, please consider donating to support the ongoing development.

Donate